BioForce Nanosciences (OTCMKTS: BFNH – Get Rating) is one of 42 public companies in the “analytical instruments” sector, but how does it differ from its peers? We’ll compare BioForce Nanosciences to related companies based on earnings strength, profitability, institutional ownership, risk, analyst recommendations, valuation, and dividends.
This table compares the net margins, return on equity and return on assets of BioForce Nanosciences and its peers.
|Net margins||Return on equity||return on assets|
|BioForce Nanosciences||N / A||N / A||-2,538.94%|
|Competitors BioForce Nanosciences||-232.11%||7.13%||-10.99%|
Insider and Institutional Ownership
61.9% of the shares of all “Analytical Instruments” companies are held by institutional investors. 39.5% of BioForce Nanosciences shares are held by insiders. By comparison, 13.0% of the shares of all “Analytical Instruments” companies are held by insiders. Strong institutional ownership indicates that hedge funds, large fund managers, and endowments believe a company will outperform the market over the long term.
Volatility and risk
BioForce Nanosciences has a beta of -1.44, indicating that its stock price is 244% less volatile than the S&P 500. Comparatively, BioForce Nanosciences peers have a beta of 1.10, indicating that their average price is 10% more volatile than the S&P. 500.
Valuation and benefits
This table compares the revenue, earnings per share (EPS), and valuation of BioForce Nanosciences and its peers.
|Gross revenue||Net revenue||Price/earnings ratio|
|Competitors BioForce Nanosciences||$1.19 billion||$356.47 million||-26.65|
BioForce Nanosciences peers have higher revenue and profit than BioForce Nanosciences. BioForce Nanosciences trades at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.
This is a summary of current ratings and recommendations for BioForce Nanosciences and its peers, as reported by MarketBeat.
|Sales Ratings||Hold odds||Buy reviews||Strong buy odds||Rating|
|BioForce Nanosciences||0||0||0||0||N / A|
|Competitors BioForce Nanosciences||323||1330||1827||58||2.46|
As a group, the “Analytical Instruments” companies have an upside potential of 26.57%. Since BioForce Nanosciences peers have higher upside potential, analysts clearly believe that BioForce Nanosciences has less favorable growth aspects than its peers.
BioForce Nanosciences peers beat BioForce Nanosciences on 8 out of 10 factors compared.
BioForce Nanosciences Company Profile (Get a rating)
BioForce Nanosciences Holdings, Inc. is focused on providing natural vitamins, minerals, other nutritional supplements, powders and beverages for people of different age groups. The company offers private label products with distributors and manufacturing suppliers. It sells its nutritional supplements to retailers, sporting goods retailers, supermarkets and mass merchandisers under the BioForce Eclipse brand, as well as online and through telemarketing. The company is based in Virginia Beach, Virginia.
Get news and reviews for BioForce Nanosciences Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for BioForce Nanosciences and related companies with MarketBeat.com’s FREE daily newsletter.